> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on ANDA Pre-submission Facility Info
- URL: https://www.fdaweb.com/draft-guide-on-anda-pre-submission-facility-info/
- Published: 2017-11-06T12:00:00.000Z
- Updated: 2026-09-14T23:00:15.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140053

*Federal Register* notice: FDA is making available a revised draft guidance entitled “ANDAs: Pre-Submission of Facility Information Related to Prioritized Generic Drug Applications (Pre-Submission Facility Correspondence).” The agency is revising the draft guidance because pre-submission of facility information was amended by the FDA Reauthorization Act of 2017\. FDA says that pre-submitting facility information enables it to determine whether a facility inspection is necessary. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-11-06/pdf/2017-24099.pdf?ref=fdaweb.com).